| Development and formulation of a 0.2% oral solution of midazolam containing γ-cyclodextrin F Marçon, D Mathiron, S Pilard, AS Lemaire-Hurtel, JM Dubaele, ... International journal of pharmaceutics 379 (2), 244-250, 2009 | 39 | 2009 |
| Population pharmacokinetic evaluation of ADV6209, an innovative oral solution of midazolam containing cyclodextrin F Marçon, C Guittet, MA Manso, I Burton, LA Granier, P Jacqmin, ... European Journal of Pharmaceutical Sciences 114, 46-54, 2018 | 31 | 2018 |
| Benefits of methylated cyclodextrins in the development of midazolam pharmaceutical formulations D Mathiron, F Marçon, J Dubaele, D Cailleu, S Pilard, F Djedaïni-Pilard Journal of Pharmaceutical Sciences 102 (7), 2102-2111, 2013 | 29 | 2013 |
| Farnesyltransferase inhibitor R115777 protects against vascular disease in uremic mice IG Nikolov, N Joki, A Galmiche, T Nguyen-Khoa, IC Guerrera, ... Atherosclerosis 229 (1), 42-51, 2013 | 20 | 2013 |
| 3, 4-Diaminopyridine may improve neuromuscular block during botulism A Friggeri, F Marçon, S Marciniak, AS Lemaire-Hurtel, AA Seydi, ... Adler 48, 867-879, 2013 | 15 | 2013 |
| A two-way randomized cross-over pharmacokinetic and pharmacodynamic study of an innovative oral solution of midazolam (ADV6209) C Guittet, M Manso, I Burton, LA Granier, F Marçon Pharmaceutical Research 34, 1840-1848, 2017 | 14 | 2017 |
| β ‐Alkylated oligomaltosides as new alternative preservatives: antimicrobial activity, cytotoxicity and preliminary investigation of their mechanism of … F Marçon, V Moreau, F Helle, N Thiebault, F Djedaïni‐Pilard, C Mullié Journal of applied microbiology 115 (4), 977-986, 2013 | 12 | 2013 |
| Cyclodextrin Complexation as a Way of Increasing the Aqueous Solubility and Stability of Carvedilol S Rigaud, D Mathiron, T Moufawad, D Landy, F Djedaini-Pilard, F Marçon Pharmaceutics 13 (11), 1746, 2021 | 9 | 2021 |
| Controlling risks in the compounding process of individually formulated parenteral nutrition: use of the FMECA method (failure modes, effects, and criticality analysis) M Royer, M Libessart, JM Dubaele, P Tourneux, F Marçon Pharmaceutical Technology in Hospital Pharmacy 4 (3-4), 105-112, 2020 | 8 | 2020 |
| Determinants of amikacin first peak concentration in critically ill patients C Boidin, S Jenck, L Bourguignon, S Torkmani, A Roussey‐Jean, ... Fundamental & Clinical Pharmacology 32 (6), 669-677, 2018 | 7 | 2018 |
| Performance qualification of two processor-controlled dosing pumps for the production of mixed infusion solutions in a closed system T Hennache, G Clabaut, L Mustapha, JM Dubaele, F Marçon Pharmaceutical Technology in Hospital Pharmacy 1 (1), 29-35, 2016 | 4 | 2016 |
| Antimicrobial preservation efficacy of liquid glucose and liquid maltitol syrups with and without 0.1% sorbic acid T Carpentier, E Maillard, M Royer, L Mustapha, F Marçon Pharmaceutical Technology in Hospital Pharmacy 6 (1), 20210007, 2021 | 1 | 2021 |
| Tailor-made medication: Practices and prospects F Bordes-Picard, C Buffangeix, MJ Celadon, J Edeline, N Fayolle, ... STP Pharma Pratiques 6, 2-6, 2020 | 1 | 2020 |
| Paediatric formulation: Budesonide 0.1 mg/mL viscous oral solution for eosinophilic esophagitis using cyclodextrins C Ey, C Hosselet, B Villon, F Marçon Pharmaceutical Technology in Hospital Pharmacy 3 (2), 71-77, 2018 | 1 | 2018 |
| Recommendations on training objectives and staff qualification for the manual preparation of capsules in pharmacy F Marçon, F Lagarce, I Roland, D Brossard, C Merienne, P Chennell, ... Pharmaceutical Technology in Hospital Pharmacy 9 (1), 20230013, 2024 | | 2024 |
| Rapid Study on Mefloquine Hydrochloride Complexation with Hydroxypropyl-β-Cyclodextrin and Randomly Methylated β-Cyclodextrin: Phase Diagrams, Nuclear Magnetic Resonance … A Durand, D Mathiron, S Rigaud, F Djedaini-Pilard, F Marçon Pharmaceutics 15 (12), 2794, 2023 | | 2023 |
| Bilan 2020 des interventions pharmaceutiques sur un secteur de nutrition parentérale M Royer, A Filattre, M Caudron, A Nowak, A Caldas, L Mustapha, ... Nutrition Clinique et Métabolisme 36 (1), S67, 2022 | | 2022 |
| Paediatric Needs: Challenge and Opportunities for Hospital Pharmacists F Marçon Pharmaceutical Technology in Hospital Pharmacy 3 (2), 47-48, 2018 | | 2018 |
| Importance du matériel utilisé pour la préparation cutanée de l'opéré A FONTENEAU, F MARCON, F DOURLENS, JM DUBAELE Hygiènes (Lyon) 17 (6), 465-468, 2009 | | 2009 |
Herve DupontCHU Amiens, CHU BichatAdresse e-mail validée de chu-amiens.fr
